ARA 290 is a derivative of erythropoietin (EPO). In vivo, ARA 290 (0.8 and 8 nmol/kg, i.p.) reduces plasma creatine, urea, and aspartate aminotransferase (AST) levels, markers of renal dysfunction, in a rodent model of renal ischemia-reperfusion injury. It decreases wound area in a rat model of punch biopsy-induced dermal injury and a rat model of decubitus ulcer. ARA 290 (30 µg/kg, i.p.) reduces the latency to find the platform in the Morris water maze in a rat model of cortical impact-induced traumatic brain injury (TBI). It also reduces tactile allodynia in a rat model of neuropathic pain induced by spinal nerve injury (SNI).
WARNING This product is not for human or veterinary use.
Be the first to review “ARA 290 Spec. 10mg (10vials/box)”
Related products
Peptides
Price range: $165.00 through $255.00
This product has multiple variants. The options may be chosen on the product page
Peptides
Price range: $55.00 through $160.00
This product has multiple variants. The options may be chosen on the product page
Peptides
Price range: $45.00 through $65.00
This product has multiple variants. The options may be chosen on the product page
Peptides
Price range: $70.00 through $100.00
This product has multiple variants. The options may be chosen on the product page
Peptides
Price range: $70.00 through $230.00
This product has multiple variants. The options may be chosen on the product page
Peptides
Price range: $60.00 through $118.00
This product has multiple variants. The options may be chosen on the product page
Reviews
There are no reviews yet.